Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × obinutuzumab × Clear all

NCT02962401 2023-08-29

RemodelWM3

Phase 2 Completed

Waldenstrom Macroglobulinemia

NCT03679455 2018-11-13

OBI-1

Phase 2 Unknown

Waldenstrom Macroglobulinemia